Dr. Gianluigi Veglia's lab at the University of Minnesota focuses on understanding the molecular basis of diseases linked to mutations in the PRKACA gene, which is crucial for regulating various cellular processes. By studying how specific mutations affect the function of protein kinase A (PKA-C), the lab aims to uncover mechanisms that may lead to conditions like Cushing's syndrome and certain types of cancer. They employ advanced techniques to analyze protein behavior in hopes of finding targeted therapies to correct these dysfunctions.

David Baker's research lab focuses on the design and development of new protein therapeutics to tackle public health challenges, particularly in response to pandemics like COVID-19. By using advanced computational techniques, the lab aims to create small proteins that can effectively neutralize viruses and mitigate severe immune responses. This research not only targets the current health crisis but also prepares methods for rapid responses to future infectious diseases.

Dr. B Franklin Pugh's lab at Cornell University investigates how genes are regulated in yeast and humans. By starting with the simpler yeast model, they aim to understand the fundamental mechanisms of gene regulation that apply across all eukaryotic life. Their research focuses on mapping the intricate interactions between proteins and DNA, which can lead to improved diagnostics and therapies for diseases in humans.

Dr. Joseph M Ready's lab studies how a specific enzyme, 15-prostaglandin dehydrogenase (15-PGDH), affects tissue healing and regeneration. They are developing small molecules that inhibit this enzyme, which could help treat various conditions involving tissue damage, such as inflammation and injury. Their research combines techniques from chemistry and biology to uncover how this enzyme functions and how its inhibition can promote recovery in the body.

Dr. Jalees Rehman's lab at the University of Illinois at Chicago focuses on understanding the interactions between pathogens and the immune system, particularly in the context of diseases like Alzheimer's and lung injuries. The lab investigates how infections can lead to cellular aging and inflammation, impacts on the blood-brain barrier in Alzheimer's patients, and utilizes advanced human organoid models to study lung disease and repair mechanisms. Their work aims to find new therapeutic targets for preventing and treating these conditions.

Dr. Kathleen Collins' research lab at UC Berkeley focuses on understanding how certain enzymes, called non-LTR retrotransposons, insert DNA sequences into genomes. By studying the structure and function of these enzymes, her team aims to develop new methods for safely delivering transgenes into human cells, which could help treat genetic diseases. They use innovative techniques in biochemistry and molecular biology to explore the unique properties of these retrotransposons and their potential therapeutic applications.

Dr. Graeme L. Conn's lab at Emory University focuses on understanding how bacterial enzymes modify ribosomal RNA to confer antibiotic resistance. By investigating the molecular details of these modifications, the lab aims to uncover new methods to combat bacterial infections and prolong the effectiveness of existing antibiotics.

Dr. Sebastian Klinge's lab at Rockefeller University studies how ribosomes, the molecular machines responsible for protein synthesis, are assembled in cells. The lab focuses on understanding the complex process of ribosome assembly, particularly the early stages that occur in the nucleolus. By integrating advanced techniques like cryo-electron microscopy and AI-based tools, the lab aims to uncover the mechanisms involved in this critical process and how errors in ribosome assembly can lead to blood disorders known as ribosomopathies.

Dr. Susan Baserga's lab at Yale University focuses on understanding the process of ribosome biogenesis and its links to human genetic diseases. They utilize innovative approaches, including genome-wide screening techniques, to identify proteins and non-coding RNAs that regulate ribosome production. By investigating how these processes affect cellular function in various tissues and during development, the lab aims to uncover the foundations of ribosomopathies, which are disorders tied to abnormal ribosome function.

Dmitri Ermolenko's lab at the University of Rochester explores how messenger RNA (mRNA) is translated into proteins by the ribosome, a complex molecular machine essential for life. They investigate the structural dynamics of the ribosome and how the shape of mRNA affects its translation efficiency, which is crucial for understanding diseases like cancer and viral infections. Utilizing advanced microscopy and biochemical techniques, the lab aims to uncover the intricacies of protein synthesis and contribute to therapies for viral infections and cancer.

Matthew D Welch's lab at UC Berkeley focuses on understanding how the Rickettsia bacteria invade host cells and survive within them. They explore the molecular mechanisms that allow these pathogens to escape immune responses and move within cells. This research is not only crucial for creating effective diagnostics and treatments for diseases caused by Rickettsia but also enhances our overall understanding of host-pathogen interactions.

Dr. Thomas Westbrook's lab at Baylor College of Medicine focuses on developing innovative strategies to treat triple-negative breast cancer (TNBC), a particularly aggressive form of cancer. The lab studies how manipulating RNA splicing can activate the immune response against tumors, potentially improving the efficacy of cancer therapies. By understanding the relationship between RNA splicing and immune signaling, the lab aims to enhance treatment outcomes for TNBC patients.

The Mathews lab at the University of Rochester focuses on understanding RNA molecules, which play crucial roles in biology and can be used in pharmaceuticals. They work on developing software and algorithms to predict RNA structures, which are vital for their functions. By studying these structures, the lab aims to contribute to our understanding of disease mechanisms and the development of RNA-based drugs.

Dr. Robert G. Roeder's lab at Rockefeller University focuses on understanding how specific proteins interact to control the formation and function of fat cells, which play a crucial role in metabolic health. The lab uses a combination of biochemical techniques and animal studies to explore how these interactions can impact conditions like obesity and diabetes. This research aims to uncover new potential treatments for metabolic disorders by examining the underlying mechanisms of fat cell behavior.

Dr. Alan L. Rothman's lab at the University of Rhode Island focuses on understanding how vaccinations against the dengue virus create lasting immunity. By studying immune responses over time in individuals who received the dengue vaccine, the lab aims to find out what makes some immune responses strong and enduring while others fade. This research could help improve future vaccine designs.

Dr. James C. Sacchettini's lab focuses on improving tuberculosis treatment by exploring the mycobacterial cell wall, which is crucial for the bacteria's survival. The team investigates how to make existing antibiotics more effective by understanding and exploiting synergies between different drugs. Their ultimate goal is to develop new combination therapies that can overcome drug resistance and accelerate TB treatment.

Dr. Aziz Sancar's research lab at UNC Chapel Hill focuses on understanding how DNA damage and repair processes are influenced by the circadian clock — the body’s internal clock that regulates biological rhythms. The lab employs innovative techniques to map DNA damage and repair at a single-nucleotide level, aiming to improve cancer treatment and prevention by linking these mechanisms to health outcomes. By exploring the relationships between DNA repair, environmental carcinogens, and chronotherapy, the lab contributes significantly to our understanding of cancer biology and personalized medicine.

Dr. Charles R. Sanders’ lab at Vanderbilt University studies Charcot-Marie-Tooth Disease (CMT), a genetic disorder that affects the nerves and causes muscle weakness. The lab is particularly interested in understanding how mutations in a specific protein called PMP22 lead to the disease. By investigating how PMP22 is processed within cells, the lab aims to uncover the mechanisms behind this condition and seek potential therapeutic targets.

Dr. Yogesh K Gupta's lab focuses on understanding how the SARS-CoV-2 virus modifies its RNA to evade the human immune system. By studying a specific protein complex that adds a chemical cap to the viral RNA, the lab aims to uncover mechanisms that can help develop therapies for COVID-19 and potentially other viral infections. The research combines structural biology, molecular tools, and drug development to create innovative antiviral treatments.

Dr. Isaac T. Schiefer's lab at the University of Toledo focuses on understanding the effects and toxicity of synthetic psychoactive substances known as bath salts. The research aims to identify drug targets and develop novel therapeutic strategies to address substance abuse disorders and the associated health risks. The lab combines molecular biology techniques with behavioral studies to gain comprehensive insights into how these substances interact with the brain and body.